Laurus Labs Ltd.

NSE: LAURUSLABS | BSE: 540222 | ISIN: INE947Q01028 | Industry: Pharmaceuticals
| Expensive Star
642.0500 1.40 (0.22%)
NSE Jun 06, 2025 15:31 PM
Volume: 1.7M
 

logo
Laurus Labs Ltd.
25 Oct 2024
642.05
0.22%
KRChoksey
Laurus Labs’ revenue missed our estimate due to weak demand in the Generic API segment. The profitability missed our estimates significantly due to operating deleverage and lower utilization.
Number of FII/FPI investors increased from 237 to 259 in Mar 2025 qtr.
More from Laurus Labs Ltd.
Recommended